Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
8.57
Oct 29 • 3:59 PM ET Dollar change-1.43 Percentage change(-14.30%)
Aftermarket Close
8.64
Aftermarket • 5:21 PM ET Dollar change+0.07 Percentage change(0.80%)
Today, 4:30 AMHaleon’s guidance cut and Q3 sales miss send ADRs down 11.8% pre-market
Index
-
Market Cap
37.69B
Enterprise Value
47.62B
Income
2.18B
Sales
14.97B
Book/sh
4.96
Cash/sh
0.25
Employees
-
IPO
Jul 18, 2022
P/E
17.62
Forward P/E
14.21
PEG
1.69
P/S
2.52
P/B
1.73
P/C
34.38
P/FCF
13.70
EV/EBITDA
12.02
EV/Sales
3.18
Quick Ratio
0.52
Current Ratio
0.69
Debt/Eq
0.50
LT Debt/Eq
0.38
Option/Short
Yes / Yes
EPS (ttm)
0.49
EPS next Y
0.60
EPS next Q
0.15
EPS this Y
9.44%
EPS next Y
8.29%
EPS next 5Y
8.43%
EPS past 3/5Y
20.04% 9.00%
Sales past 3/5Y
2.82% 2.76%
EPS Y/Y TTM
12.37%
Sales Y/Y TTM
4.99%
EPS Q/Q
24561.95%
Sales Q/Q
15.22%
Insider Own
0.00%
Insider Trans
-
Inst Own
13.87%
Inst Trans
-1.37%
ROA
5.02%
ROE
9.99%
ROIC
7.24%
Gross Margin
65.46%
Oper. Margin
23.31%
Profit Margin
14.55%
SMA20
-11.01%
SMA50
-10.38%
SMA200
-12.30%
Trades
Shs Outstand
4.40B
Shs Float
4.40B
52W High
11.28 -24.02%
52W Low
8.65 -0.92%
Volatility
1.49% 1.60%
ATR (14)
0.29
RSI (14)
30.93
Beta
0.12
Rel Volume
3.74
Avg Volume
15.18M
Volume
56,761,913
Perf Week
-17.36%
Perf Month
-4.78%
Perf Quarter
-13.17%
Perf Half Y
-7.25%
Perf YTD
-15.23%
Perf Year
-5.30%
Perf 3Y
10.15%
Perf 5Y
-
Perf 10Y
-
Prev Close
10.00
Price
8.57
Change %
-14.30%
Consensus
Buy
Avg. Price Target
$11.03
Implied Upside
+28.7%
Analysts10incl. previous ratings
Rating Distribution7 Buy · 3 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jan 23, 2026Upgrade
BCS logoBBarclays
Equal Weight → Overweight
Sep 16, 2025Downgrade
BCS logoBBarclays
Overweight → Equal Weight
Sep 10, 2025Upgrade
GS logoGGoldman
Neutral → Buy
May 27, 2025Upgrade
BBNP Paribas Exane
Neutral → Outperform$13.40+56.4%
May 09, 2025Upgrade
MS logoMMorgan Stanley
Equal-Weight → Overweight$11.25+31.3%
Mar 05, 2025Downgrade
HSBC logoHHSBC Securities
Buy → Hold
Jan 10, 2025Downgrade
MS logoMMorgan Stanley
Overweight → Equal-Weight
Jan 08, 2025Downgrade
BBernstein
Outperform → Mkt Perform
Aug 06, 2024Initiated
BBerenberg
Buy
Aug 06, 2024Downgrade
GS logoGGoldman
Buy → Neutral
Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom.
CEO & Executive DirectorMr. Brian James McNamara
CFO & DirectorMs. Dawn Amanda Allen
Chief Digital & Technology OfficerMs. Claire Dickson
Head of Investor RelationsMs. Joanne Russell
General CounselMr. Adrian Charles Morris